Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-11-15
2005-11-15
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S380000, C514S340000, C514S236800, C546S272100, C544S137000, C548S214000, C548S245000
Reexamination Certificate
active
06964975
ABSTRACT:
The present invention relates to novel isoxazole and thiazole compounds having an excellent lysophosphatidic acid (LPA) receptor antagonistic activity represented by general formula [1] or salts thereof:wherein R1 and R2 represents an optionally substituted alkyl group or the like; R3 represents a hydrogen atom or the like; R4 represent a group selected from the group consisting of (I) optionally substituted phenyl, aryl, or heterocycle, (II) substituted or nonsubstituted alkyl, and (III) substituted or nonsubstituted alkenyl, alternatively, R3 and R4 may form a ring structure together with a carbon atom to which they bind; and X represents an oxygen atom or a sulfur atom, provided that, when R3 is a hydrogen atom, R4 represents a group other than methyl, and the use thereof as a medicine.
REFERENCES:
patent: 5861359 (1999-01-01), Theodoridis
patent: 6403791 (2002-06-01), Dyke et al.
patent: WO 95/13075 (1995-05-01), None
patent: WO 98/27213 (1998-06-01), None
patent: WO 01/34573 (2001-05-01), None
Drummond et al., J. Med. Chem. (1989), 32(9), pp. 2116-2128.
CA Registry No. 261714-80-1, entry date in Registry file is Apr. 12, 2000.
CA Registry No. 261714-57-2, entry date in Registry file is Apr. 12, 2000.
CA Registry No. 261622-75-7, entry date in Registry file is Apr. 11, 2000.
CA Registry No. 257284-80-3, entry date in Registry file is Feb. 29, 2000.
Reiter, Journal of Organic Chemistry (1987), 52(13), pp. 2714-2726.
Pharmazie, 1994, vol. 49, No. 10, pp. 727-729.
Database Crossfire Beilstein *Online! Beilstein Institut zur Forderung der Chemischen Wissenschaften, Frankfurt am Main, DE; Database accession No. 997021 XP002232339, 3,5-dimethyl-4 benzyloxycarbonylamino-isothiazole *abstract* & Indian J. Chem., vol. 7, 1969, pp. 103-105.
Database Crossfire Beilstein *Online! Beilstein institut zur Forderung der Chemischen Wissenschaften, Frankfurt am Main, DE; Database accession No. 920183 XP002232340 (5-methyl-3-phenyl-isoxazole-4-yl)- carbamic acid ethyl ester *abstact* & Pharm Chem. J., vol.7, 1968, pp. 388-389.
Nagao Rika
Ohta Hideo
Ueno Akihiro
Watanabe Tomoko
Yagi Mikio
Foley & Lardner LLP
Kirin Beer Kabushiki Kaisha
Stockton Laura L.
LandOfFree
Isoxazole and thiazole compounds and use thereof as medicine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoxazole and thiazole compounds and use thereof as medicine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoxazole and thiazole compounds and use thereof as medicine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3478782